GetTopicDetailResponse(id=eaed1288e96c, topicName=序貫放化療, introduction=, content=鼻咽癌 序貫放化療, image=null, comments=0, allHits=103, url=null, type=0, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Sat Jul 26 12:25:47 CST 2025, time=2025-07-26, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=109350, tagList=[TagDto(tagId=109350, tagName=序貫放化療)], ipAttribution=上海, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2274904, encodeId=fdeb22e49046a, content=<a href='/topic/show?id=c3f910342343' target=_blank style='color:#2F92EE;'>#鼻咽癌#</a> <a href='/topic/show?id=eaed1288e96c' target=_blank style='color:#2F92EE;'>#序貫放化療#</a>, objectTitle=3年無失敗生存率83.7%！針對(duì)這種中國南方高發(fā)癌癥，復(fù)旦腫瘤團(tuán)隊(duì)帶來更優(yōu)治療方案, objectType=article, longId=888444, objectId=7cee88844401, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20220801/1659342224826_8252897.webp, objectUrl=/article/show_article.do?id=7cee88844401, replyNumber=0, likeNumber=11, createdTime=2025-07-26, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=7cee88844401, moduleTitle=3年無失敗生存率83.7%！針對(duì)這種中國南方高發(fā)癌癥，復(fù)旦腫瘤團(tuán)隊(duì)帶來更優(yōu)治療方案, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=7cee88844401)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2025-07-26發(fā)表于上海
